By For patients with dementia with Lewy bodies (DLB), treatment with acetylcholinesterase inhibitors (AChEIs) and/or memantine is associated with reduced hospital admissions and mortality, according to a study published online Dec. 6 in PLOS Medicine.
Drop in mortality seen with AChEI, memantine in dementia with lewy bodies
AI background business technology, digital transformation
Comments